Toshihiko Yamaguchi Selected Research

Toshihiko Yamaguchi Research Topics

11	Neoplasms (Cancer) 01/2022 - 09/2004
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2004
7	Adenocarcinoma of Lung 01/2021 - 08/2005
6	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2005
4	Disease Progression 01/2021 - 11/2017
4	Neoplasm Metastasis (Metastasis) 11/2017 - 09/2004
3	Carcinoma (Carcinomatosis) 01/2021 - 09/2015
2	Pericardial Effusion 12/2018 - 01/2017
2	Adenocarcinoma 09/2015 - 09/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 03/2015
2	Tuberculosis (Tuberculoses) 05/2012 - 04/2011
1	Asphyxia (Suffocation) 01/2021
1	Antisynthetase syndrome 01/2021
1	Idiopathic Pulmonary Fibrosis 11/2020
1	Pneumonia (Pneumonitis) 05/2018
1	Vitiligo 01/2017
1	Small Cell Carcinoma 09/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2015
1	Hypersensitivity (Allergy) 03/2015
1	Communicable Diseases (Infectious Diseases) 05/2012
1	Pleural Tuberculosis 05/2012
1	Alcoholic Hepatitis 01/2012
1	Purpura 04/2011
1	Neutropenia 04/2011
1	Thrombocytopenia chromosome breakage 04/2011
1	Thrombocytopenia (Thrombopenia) 04/2011
1	Pneumothorax 08/2005
1	Brain Neoplasms (Brain Tumor) 09/2004
1	Body Weight (Weight, Body) 02/2003

5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
5	NivolumabIBA 11/2020 - 01/2017
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2004
3	SteroidsIBA 01/2021 - 02/2003
3	SurvivinIBA 09/2015 - 12/2014
3	Gefitinib (Iressa)FDA Link 01/2012 - 09/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 11/2020
2	pembrolizumabIBA 11/2020 - 11/2018
2	Monoclonal AntibodiesIBA 12/2018 - 01/2017
2	PlatinumIBA 11/2018 - 07/2006
2	Tyrosine Kinase InhibitorsIBA 01/2012 - 09/2004
1	Pemetrexed (MTA)FDA Link 01/2021
1	osimertinibIBA 01/2021
1	Cytotoxins (Cytolysins)IBA 11/2020
1	pirfenidoneIBA 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	B7-H1 AntigenIBA 11/2018
1	Anaplastic Lymphoma KinaseIBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Albumin-Bound Paclitaxel FDA Link 03/2015
1	Docetaxel (Taxotere)FDA Link 03/2015
1	Cisplatin (Platino)FDA LinkGeneric 03/2015
1	VimentinIBA 09/2014
1	Chemokine CXCL12IBA 05/2012
1	Biomarkers (Surrogate Marker)IBA 05/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2012
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2011
1	Pyrazinamide FDA LinkGeneric 04/2011
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2011
1	Ethambutol (Myambutol)FDA LinkGeneric 04/2011